Blood Pressure and Glucose Lowering Diet for Taiwanese
Taiwan_DASH
Design and Testing Efficacy of Blood Pressure and Glucose Lowering Diet for Taiwanese Pre-/1st Staged Hypertension Patients and/or Pre-diabetes Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
Prevalence rates of hypertension and diabetes are high in Taiwan. Little attention is given to evidence-based dietary therapy in Taiwan. Patients, after confirmed diagnosis, are mostly prescribed with medications without comprehensive instructions on dietary therapy. DASH diet has been proven to be an effective dietary approach to reduce blood pressure for hypertension patients in US. However, dietary difference and patient profiles across countries are evident. In addition, hypertensive patients are often combined with hyperglycemia. Carbohydrate burden of DASH diet may be higher than most dietitians desire. Therefore, the investigators in tend to design a Taiwanese DASH diet and a lower carbohydrate DASH diet and test their efficacy on both blood pressure and fasting glucose lowering.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Nov 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 31, 2011
CompletedFirst Posted
Study publicly available on registry
June 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 2, 2011
May 1, 2011
1.1 years
May 31, 2011
June 1, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blood pressure
Baseline and per week after intervention
4 weeks
Secondary Outcomes (2)
Fasting blood glucose, fasting insulin, cholesterol, triglycerides, HDL-C and LDL-C
will be measured at 0, 2, 4, 8, 10 and 12 weeks
Urinary magnesium, potassium, sodium and creatinine
will be measured at 0, 2, 4, 8, 10 and 12 weeks
Study Arms (2)
DASH diet
ACTIVE COMPARATORlower carbohydrate DASH diet
ACTIVE COMPARATORInterventions
DASH diet: A diet rich in whole grain, fruit and vegetable, low-fat dairy products, white meat and nuts; and lower of total fat and saturated fat.
lower carbohydrate DASH diet: A DASH diet with lower carbohydrate percentage
Eligibility Criteria
You may qualify if:
- Age 20-65 years, weight 50-80 kg(±5kg)
- Two blood pressure readings and fasting blood glucose measurements:
- fasting blood glucose of 100-125 ml/dL and not using antidiabetic medication.
- systolic blood pressure of 130-159 mmHg or diastolic blood pressure of 85-99 mmHg and not using antihypertensive medication.
You may not qualify if:
- (a) taking blood glucose lowering, antihypertensive or oral steroid medications.
- (b) history of stroke, cardiovascular disease, abnormal liver function, cancer, stomach ulcer, inflammatory bowel disease or other chronic diseases that will influence the diet of participants.
- (c) Major surgery in the past year or about to undergo major surgery.
- (d) Is the holder of a major illness card.
- (e) Takes antipsychotics.
- (f) Harmful drinker (more than 14 drinks per week)
- (g) Has food allergies or food intolerance.
- (h) Pregnant or breastfeeding.
- (i) Unwilling to cease intake of vitamin or mineral supplements or antacids containing magnesium or calcium for the duration of the study.
- (j) Other medications or physiological states influencing the absorption of nutrients.
- (k) Other individuals deemed unsuitable to participate in the intervention by their treating physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Health Research Institutes
Miaoli County, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wen-Han Pan, Ph. D.
National Health Research Institutes, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 31, 2011
First Posted
June 2, 2011
Study Start
November 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
June 2, 2011
Record last verified: 2011-05